LM2024 Skip to main content
LM2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Separate Fee
Separate Fee
Research Poster
Research Poster
Reception
Reception
No CME/CE
No CME/CE
Meal
Meal
Coffee Break
Coffee Break
Sold Out
Sold Out
Back

Elizabeth Beale, MD, MRCP (UK) DipABLM

CEO
Alsteni Medical, Inc.
Los Angeles, California, United States

Elizabeth Beale (Demetriades), MD, MRCP (UK) Dip ABLM is the former Clinical Director of the Roybal Diabetes Management Program in East Los Angeles and Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at the Keck School of Medicine at the University of Southern California. She trained as an internist and endocrinologist in South Africa in the 1980s towards the end of the apartheid era. She moved to Los Angeles in the early 1990s at the height of the AIDs epidemic where she retrained in internal medicine and endocrinology at LAC+USC Medical Center. She became a faculty member in the Division of Endocrinology in 2005 with a research and clinical focus on type 2 diabetes. Over the years it became apparent that lifestyle factors are the main drivers of type 2 diabetes and related chronic metabolic disorders. Furthermore, the standard pharmacological treatment is very difficult to implement, very expensive, often ineffective and contributes to stress in patients’ lives, and burnout in clinicians. In 2019 she attended her first lifestyle medicine conference, “found her tribe” and became a Diplomate of the American Board of Lifestyle Medicine. She is determined to share her new knowledge regarding lifestyle medicine with her colleagues and patients. She is co-founder and current Chair of the ACLM Endocrine Member Interest Group. She also currently serves as the Lifestyle Medicine Program Chair of the Charles Drew University "Echo West" Program and is a member of the ACLM "GLP-1 Agonist Task Force".

Disclosure information not submitted.

Presentation(s):